Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD

M Miravitlles, A Auladell-Rispau… - European …, 2021 - Eur Respiratory Soc
Inhaled corticosteroids (ICSs) are indicated for the prevention of exacerbations in COPD;
however, a significant proportion of patients at low risk of exacerbations are treated with …

Glucocorticoid-induced osteoporosis

L Buckley, MB Humphrey - New England Journal of Medicine, 2018 - Mass Medical Soc
Key Clinical Points Glucocorticoid-Induced Osteoporosis Risk factors for glucocorticoid-
induced fractures include age (> 55 years), female sex, white race, and long-term use of …

Long-term triple therapy de-escalation to indacaterol/glycopyrronium in patients with chronic obstructive pulmonary disease (SUNSET): a randomized, double-blind …

KR Chapman, JR Hurst, SM Frent, M Larbig… - American journal of …, 2018 - atsjournals.org
Rationale: There are no studies on withdrawal of inhaled corticosteroids in patients on long-
term triple therapy in the absence of frequent exacerbations. Objectives: To evaluate the …

Association of potent and very potent topical corticosteroids and the risk of osteoporosis and major osteoporotic fractures

A Egeberg, P Schwarz, T Harsløf… - JAMA …, 2021 - jamanetwork.com
Importance Systemic and inhaled corticosteroids negatively affect bone remodeling and
cause osteoporosis and bone fracture when given continuously or in high doses. However …

Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 …

OD Messina, M Vidal, JAM Torres, LF Vidal… - Aging clinical and …, 2022 - Springer
Guidelines and recommendations developed and endorsed by the International
Osteoporosis Foundation (IOF) are intended to provide guidance for particular pattern of …

Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: an update of Brazilian Society of Rheumatology (2020)

RMR Pereira, MO Perez, AP Paula, C Moreira… - Archives of …, 2021 - Springer
The Brazilian guidelines for prevention and treatment of glucocorticoid-induced
osteoporosis were updated and important topics were included such as assessment of risk …

[HTML][HTML] Reducing the risk of mortality in chronic obstructive pulmonary disease with pharmacotherapy: a narrative review

M Mintz, I Barjaktarevic, DA Mahler, B Make… - Mayo Clinic …, 2023 - Elsevier
In 2020, chronic obstructive pulmonary disease (COPD) was the fifth leading cause of death
in the United States excluding COVID-19, and its mortality burden has been rising since the …

Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study

DB Price, J Voorham, G Brusselle, A Clemens… - NPJ primary care …, 2019 - nature.com
Some studies suggest an association between onset and/or poor control of type 2 diabetes
mellitus and inhaled corticosteroid (ICS) therapy for chronic obstructive pulmonary disease …

Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study

C Janson, K Lisspers, B Ställberg… - European …, 2021 - Eur Respiratory Soc
The effect of inhaled corticosteroids (ICS) on the risk of osteoporosis and fracture in patients
with chronic obstructive pulmonary disease (COPD) remains uncertain. The aim of this study …

The impact of osteoporosis and vertebral compression fractures on mortality and association with pulmonary function in COPD: a meta-analysis

L Kakoullis, F Sampsonas, V Karamouzos, G Kyriakou… - Joint Bone Spine, 2022 - Elsevier
Objective Osteoporosis is highly prevalent among patients with chronic obstructive
pulmonary disease (COPD) and most commonly presents as a vertebral compression …